Transorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest
Key facts
- Who runs it
- University Hospital Pilsen
- Where
- Czechia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 80 people, planned
- Started
- 4 Jan 2021
- Expected to end
- 1 Dec 2026
- Type of study
- Observational
- Treatments tested
- Optic nerve sheath diameter measured by transorbital ultrasound
- Record updated
- 9 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- age of 18 years or older
- out of hospital cardiac arrest of non-traumatic cause with CPR and subsequent ROSC
- Glasgow coma scale (GCS) ≤ 7 or sedation 30 minutes after ROSC achievment
Who cannot take part
- refractory cardiac arrest
- active intracranial bleeding
- haemorrhagic stroke and/or subarachnoid haemorrhage in the last 3 months
- active neuroendocrine tumor, small cell lung cancer, non-small cell lung
- CPC 3-5 before cardiac arrest
- unavailable first measurment of the optic nerve sheath diameter (ONSD) measured by transorbital ultrasonography 24±6 hours after ROSC achievement
- craniocerebral injury
- intracranial tumor
- facial trauma affecting the eye area
- sclerosis multiplex and/or optic neuritis of other etiology
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In sudden cardiac arrest patients with return of spontaneous circulation, brain damage is one of the main determinants of short-term mortality and poor prognosis (CPC 3-5). It is important to properly select group of patients in whom treatment is futile. According to current guidelines, multimodal approach is recommended. Optic nerve sheath diameter measured by ultrasound is non-invasive, fast, low-cost and readily available bed-side method, but evidence for its use as neuroprognostication modality is limited to only few small studies. The aim of this study is to evaluate validity of ONSD as neuroprognostication method at larger cohort of patients, compare it with other established methods and compare ultrasound and CT measurement of ONSD.
Treatments tested
- Optic nerve sheath diameter measured by transorbital ultrasound
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest (TOMCAT)
- Record updated
- 9 April 2026